Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
9.56
+0.03 (0.31%)
Feb 21, 2025, 4:00 PM EST - Market closed
Mineralys Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 476 | 613 | 354 | - | - | - |
| Market Cap Growth | 73.31% | 73.31% | - | - | - | - |
| Enterprise Value | 278 | 349 | 100 | - | - | - |
| Last Close Price | 9.56 | 12.31 | 8.60 | - | - | - |
| PB Ratio | 2.49 | 3.20 | 1.47 | - | - | - |
| P/TBV Ratio | 3.20 | 3.20 | 1.47 | - | - | - |
| Debt / Equity Ratio | - | - | - | - | - | -1.25 |
| Quick Ratio | 13.53 | 13.53 | 22.57 | 13.65 | 2.10 | 0.28 |
| Current Ratio | 14.02 | 14.02 | 23.76 | 13.98 | 2.20 | 0.29 |
| Return on Equity (ROE) | -82.24% | -82.24% | -41.38% | -53.00% | -1568.96% | - |
| Return on Assets (ROA) | -52.56% | -52.56% | -28.91% | -31.34% | -185.60% | - |
| Return on Capital (ROIC) | -55.62% | -55.62% | -30.45% | -34.99% | -335.62% | - |
| Earnings Yield | -37.32% | -29.02% | -20.34% | - | - | - |
| FCF Yield | -34.93% | -27.16% | -22.96% | - | - | - |
| Buyback Yield / Dilution | -34.13% | -34.13% | -600.33% | -3.67% | -7.64% | - |
| Total Shareholder Return | -34.13% | -34.13% | -600.33% | -3.67% | -7.64% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.